Analyst Consensus ?
ConsensusBuy51 ratings
Bullish2956.9%
Neutral2039.2%
Bearish23.9%
FN2 Earnings Intelligence
Fifth Third Bancorp (FITB) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Buy | Buy | Maintain | Oct 22, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Oct 21, 2026 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Oct 21, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 20, 2026 |
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 2, 2026 |
| Truist Securities | Buy | Buy | Maintain | Sep 23, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jul 20, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 20, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 29, 2026 |
| Baird | Outperform | Outperform | Maintain | Jun 8, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 20, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Mar 30, 2026 |
| TD Cowen | Buy | Buy | Maintain | Feb 3, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 22, 2024 |
| Jefferies | Buy | Buy | Maintain | Jul 3, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | May 31, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 18, 2023 |
| Wedbush | Outperform | Outperform | Maintain | Jul 21, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Sep 12, 2022 |
| CFRA | Buy | Buy | Maintain | Apr 22, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| Odeon Capital | Hold | Hold | Maintain | Dec 6, 2019 |
| Raymond James | Outperform | Outperform | Maintain | Oct 23, 2019 |
| Bank of America | Buy | Buy | Maintain | Oct 23, 2019 |
| BMO Capital | Market Perform | Market Perform | Maintain | Apr 25, 2019 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Apr 4, 2019 |
| Argus | Buy | Buy | Maintain | Jun 14, 2018 |
| Macquarie | Underperform | Neutral | Downgrade | Nov 17, 2017 |
| Compass Point | Buy | Neutral | Upgrade | Mar 29, 2017 |
| Hilliard Lyons | Neutral | Underperform | Upgrade | Jan 25, 2017 |
| Bernstein | Market Perform | Outperform | Downgrade | Nov 16, 2016 |
| CLSA | Outperform | Outperform | Maintain | Sep 23, 2016 |
| Oppenheimer | Perform | Outperform | Downgrade | Jul 6, 2016 |
| Susquehanna | Neutral | Positive | Downgrade | Jun 7, 2016 |
| Sterne Agee CRT | Neutral | Buy | Downgrade | Apr 6, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Apr 6, 2016 |
| Credit Suisse | Underperform | Underperform | Maintain | Mar 10, 2016 |
| PiperJaffray | Neutral | Neutral | Maintain | Nov 23, 2015 |
| Guggenheim | Neutral | Buy | Downgrade | Oct 21, 2015 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Jun 29, 2015 |
| FBR Capital | Market Perform | Outperform | Downgrade | Jan 22, 2015 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Dec 16, 2013 |
| Rafferty Capital | Hold | Buy | Downgrade | Nov 6, 2013 |
| Rafferty | Hold | Buy | Downgrade | Nov 6, 2013 |
| ISI Group | Buy | Buy | Maintain | Oct 7, 2013 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Feb 11, 2013 |
| Stifel | Hold | Buy | Downgrade | Feb 11, 2013 |
| Miller Tabak | Strong Buy | Strong Buy | Maintain | Aug 27, 2012 |
Upside is calculated against the persisted current price $53.59. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stephens | Matt Olney | $59 | $52.41 | +10.1% | Oct 21, 2026 |
| RBC Capital | Analyst unavailable | $60 | $51.67 | +12.0% | Oct 20, 2026 |
| UBS | Analyst unavailable | $63 | $50.87 | +17.6% | Oct 5, 2026 |
| Truist Financial | Analyst unavailable | $63 | $52.76 | +17.6% | Sep 23, 2026 |
| D.A. Davidson | Analyst unavailable | $65 | $57.96 | +21.3% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $62 | $58.01 | +15.7% | Jul 20, 2026 |
| UBS | Erika Najarian | $65 | $58.27 | +21.3% | Jul 7, 2026 |
| Evercore ISI | Analyst unavailable | $60 | $57.72 | +12.0% | Jul 6, 2026 |
| Wells Fargo | Analyst unavailable | $67 | $57.16 | +25.0% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $58 | $52.01 | +8.2% | Jun 8, 2026 |
| Truist Financial | Analyst unavailable | $57 | $51.05 | +6.4% | Apr 21, 2026 |
| Evercore ISI | Analyst unavailable | $53 | $51.68 | -1.1% | Apr 21, 2026 |
| Barclays | Jason Goldberg | $63 | $50.34 | +17.6% | Apr 20, 2026 |
| Evercore ISI | Analyst unavailable | $57 | $53.48 | +6.4% | Feb 5, 2026 |
| UBS | Erika Najarian | $59 | $54.57 | +10.1% | Feb 4, 2026 |
| Truist Financial | Analyst unavailable | $60 | $50.23 | +12.0% | Jan 26, 2026 |
| D.A. Davidson | Peter Winter | $58 | $50.19 | +8.2% | Jan 26, 2026 |
| RBC Capital | Analyst unavailable | $57 | $51.62 | +6.4% | Jan 21, 2026 |
| Wolfe Research | Analyst unavailable | $55 | $49.1 | +2.6% | Jan 7, 2026 |
| Evercore ISI | John Pancari | $52 | $49.46 | -3.0% | Jan 6, 2026 |
| UBS | Analyst unavailable | $57 | $48.62 | +6.4% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $61 | $47.71 | +13.8% | Jan 5, 2026 |
| Truist Financial | Brian Foran | $55 | $48.1 | +2.6% | Dec 22, 2025 |
| Piper Sandler | Analyst unavailable | $50 | $45.17 | -6.7% | Dec 10, 2025 |
| Stephens | Analyst unavailable | $52 | $42.2 | -3.0% | Oct 14, 2025 |
| D.A. Davidson | Analyst unavailable | $52 | $44.03 | -3.0% | Oct 8, 2025 |
| UBS | Analyst unavailable | $45 | $43.67 | -16.0% | Oct 7, 2025 |
| Morgan Stanley | Manan Gosalia | $60 | $43.79 | +12.0% | Oct 7, 2025 |
| Evercore ISI | Analyst unavailable | $49 | $45.4 | -8.6% | Sep 30, 2025 |
| Morgan Stanley | Manan Gosalia | $56 | $45.43 | +4.5% | Sep 29, 2025 |
| D.A. Davidson | Peter Winter | $47 | $39.58 | -12.3% | Jun 9, 2025 |
| D.A. Davidson | Peter Winter | $46 | $43.37 | -14.2% | Oct 21, 2024 |
| Citigroup | Keith Horowitz | $43 | $44.67 | -19.8% | Oct 21, 2024 |
| Piper Sandler | Scott Siefers | $48 | $41.76 | -10.4% | Oct 3, 2024 |
| Stephens | Terry McEvoy | $42 | $39.8 | -21.6% | Sep 11, 2024 |
| Piper Sandler | Scott Siefers | $45 | $42.34 | -16.0% | Sep 3, 2024 |
| Argus Research | Stephen Biggar | $46 | $40.42 | -14.2% | Jul 22, 2024 |
| RBC Capital | Gerard Cassidy | $43 | $40.99 | -19.8% | Jul 22, 2024 |
| D.A. Davidson | Peter Winter | $42 | $40.99 | -21.6% | Jul 22, 2024 |
| Wells Fargo | Mike Mayo | $42 | $35.28 | -21.6% | Jun 12, 2024 |
| Wolfe Research | Bill Carcache | $43 | $36.75 | -19.8% | May 31, 2024 |
| UBS | Erika Najarian | $39 | $36.05 | -27.2% | Apr 4, 2024 |
| Robert W. Baird | David George | $32 | $37.21 | -40.3% | Apr 1, 2024 |
| Stephens | Terry McEvoy | $41 | $35.43 | -23.5% | Mar 19, 2024 |
| Raymond James | David Long | $4.5 | $51.41 | -91.6% | Jan 19, 2024 |
| Barclays | Analyst unavailable | $47 | $32.81 | -12.3% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $36 | $31.94 | -32.8% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $37 | $33.28 | -31.0% | Dec 5, 2022 |
| Morgan Stanley | Analyst unavailable | $43 | $33.96 | -19.8% | Jul 12, 2022 |
| UBS | Erika Najarian | $56 | $48.88 | +4.5% | Jan 12, 2022 |
| Barclays | Jason Goldberg | $53 | $44.38 | -1.1% | Jan 3, 2022 |
| Argus Research | Stephen Biggar | $49 | $44.98 | -8.6% | Oct 20, 2021 |
| Stephens | Terry McEvoy | $48 | $44.98 | -10.4% | Oct 20, 2021 |
| KBW | David Konrad | $42 | $36.57 | -21.6% | Jul 6, 2021 |
Track every rating change on FITB the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.